Baricitinib: A chance to treat COVID‐19?
2020; Wiley; Volume: 92; Issue: 11 Linguagem: Inglês
10.1002/jmv.26033
ISSN1096-9071
AutoresSergio Lo Caputo, Gaetano Corso, Mario Clerici, Teresa Santantonio,
Tópico(s)Long-Term Effects of COVID-19
ResumoJournal of Medical VirologyVolume 92, Issue 11 p. 2343-2344 LETTER TO THE EDITOR Baricitinib: A chance to treat COVID-19? Sergio Lo Caputo, Sergio Lo Caputo orcid.org/0000-0003-0063-4575 Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalySearch for more papers by this authorGaetano Corso, Gaetano Corso orcid.org/0000-0003-4720-1320 Clinical Biochemistry and Clinical Molecular Biology, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalySearch for more papers by this authorMario Clerici, Mario Clerici orcid.org/0000-0002-2382-3638 Department of Pathophysiology and Transplantation, Don C Gnocchi Foundation IRCCS, University of Milano, Milano, ItalySearch for more papers by this authorTeresa Antonia Santantonio, Corresponding Author Teresa Antonia Santantonio [email protected] orcid.org/0000-0002-4342-6904 Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy Correspondence Teresa Antonia Santantonio, Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy. Email: [email protected]Search for more papers by this author Sergio Lo Caputo, Sergio Lo Caputo orcid.org/0000-0003-0063-4575 Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalySearch for more papers by this authorGaetano Corso, Gaetano Corso orcid.org/0000-0003-4720-1320 Clinical Biochemistry and Clinical Molecular Biology, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalySearch for more papers by this authorMario Clerici, Mario Clerici orcid.org/0000-0002-2382-3638 Department of Pathophysiology and Transplantation, Don C Gnocchi Foundation IRCCS, University of Milano, Milano, ItalySearch for more papers by this authorTeresa Antonia Santantonio, Corresponding Author Teresa Antonia Santantonio [email protected] orcid.org/0000-0002-4342-6904 Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy Correspondence Teresa Antonia Santantonio, Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy. Email: [email protected]Search for more papers by this author First published: 21 May 2020 https://doi.org/10.1002/jmv.26033Citations: 14Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Stebbing J, Phelan A, Griffin I, et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020; 20(4), https://doi.org/10.1016/S1473-3099(20)30132-8 10.1016/S1473-3099(20)30132-8 PubMedWeb of Science®Google Scholar 2Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 10.1016/S0140-6736(20)30183-5 CASPubMedWeb of Science®Google Scholar 3Richardson P, Griffin I, Tucker C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020; 395: 497-506. 10.1016/S0140-6736(20)30304-4 PubMedWeb of Science®Google Scholar 4 European Medicines Agency. Olumiant: summary of product characteristics. https://www.ema.europa.eu/en/documents/productinformation/olumiant-epar-product-information_en.pdf. Accessed on February 24, 2020. Google Scholar Citing Literature Volume92, Issue11Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐VIINovember 2020Pages 2343-2344 ReferencesRelatedInformation
Referência(s)